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X-ray crystallography requires sufficiently large crystals to obtain structural
insights at atomic resolution, routinely obtained in vitro by time-consuming screen-
ing. Recently, successful data collection was reported from protein microcrystals
grown within living cells using highly brilliant free-electron laser and third-
generation synchrotron radiation. Here, we analyzed in vivo crystal growth of fire-
fly luciferase and Green Fluorescent Protein-tagged reovirus lNS by live-cell
imaging, showing that dimensions of living cells did not limit crystal size. The
crystallization process is highly dynamic and occurs in different cellular compart-
ments. In vivo protein crystallization offers exciting new possibilities for proteins
that do not form crystals in vitro. VC 2015 Author(s). All article content, except
where otherwise noted, is licensed under a Creative Commons Attribution 3.0
Unported License. [http://dx.doi.org/10.1063/1.4921591]
I. INTRODUCTION
The three-dimensional structure of a protein determines its function. Consequently, struc-
tural insights into proteins at atomic resolution are important to understand the machinery of
life or to develop new specifically designed drugs for medical applications. Synchrotron-based
x-ray crystallography, the preferred technique for obtaining structural information at high reso-
lution, accounts for almost 90% of the over 107.000 protein structures deposited within the
Protein Data Bank (PDB, www.pdb.org) to date. Despite the revolutionary success during the
past decades, the correlation between crystal size, diffraction intensity, resolution, and radiation
damage usually requires the growth of sufficiently large and well-ordered single crystals and
thus emphasizes one of the major bottlenecks of this method.1,2 The deposited energy triggers a
variety of chemical reactions that finally reduce the crystalline order, leading to a quick deterio-
ration of the diffraction data quality as a function of the applied x-ray dose, even under cryo-
genic conditions.3,4 Lowering the incident fluency to reduce radiation damage in turn requires
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the growth of large crystals to yield sufficient diffraction intensities, which is difficult in many
cases, particularly for post-translationally modified proteins and membrane proteins.5
Conventional protein crystallization in artificial crystallization chambers requires the pro-
motion of the nucleation process when a supersaturated sample solution is introduced to a pre-
cipitating agent in vitro. If the environmental conditions fit, the growth of large three-
dimensional crystals may result. This process is affected by a wide range of parameters, gener-
ating a vast multidimensional space that must be screened to meet the desired conditions yield-
ing crystals. In modern crystallization approaches, pipetting robot-assisted sparse matrix screen-
ing approaches are routinely performed to test the potential crystallization space applying vapor
diffusion and batch crystallization techniques. Although the success rate has significantly
improved to date, there is still no guarantee for protein crystal formation.6,7
For more than a century, it has been known that protein crystallization also represents a
native, if somewhat rare, process within living cells.8 Intracellular crystalline states of proteins
are associated with diverse cellular functions, as observed for storage proteins in seeds,9–11 in-
sulin in pancreatic b-cells,12 enzymes in peroxisomes,13 and bacterial toxins.14 Moreover, spon-
taneous crystal formation in vivo may also occur as a result of heterologous gene overexpres-
sion. Polyhedrin, a viral protein that usually forms a crystalline coat to protect virions against
environmental challenges,15 assembles into remarkably stable microcrystals within virus-
infected insect cells.16 Exploiting the permanent activation of the polyhedrin promotor, the
exchange of the polyhedrin gene by a gene of interest in a baculovirus shuttle vector results in
high local protein concentration in the baculovirus-infected insect cell, which is obviously one
prerequisite for in vivo crystal formation. Thus, protein microcrystals have been discovered sev-
eral times by applying the well-established baculovirus-Sf9 insect cell expression system that is
frequently used to produce recombinant proteins containing post-translational modifications.17
Mammalian cells also provide a suitable environment for heterologous protein crystallization,
as recently demonstrated.18–20 However, the phenomenon of in vivo crystallization was so far
largely perceived as a rare and atypical behavior of proteins, preventing a systematic investiga-
tion of the intracellular crystallization process. The size of the crystal grown in vivo was previ-
ously considered to be necessarily limited by the cell’s outer dimensions,8,21 but such small
crystals would harbor only low diffraction capabilities and high sensitivity to radiation damage.
Thus, in vivo grown protein crystals were not considered for structural biology until recently.
This picture has significantly changed with the recent realization of novel radiation sources
that produce x-rays of previously inaccessible energy and brilliance. Exploiting the “diffraction-
before-destruction” paradigm22 by using highly brilliant x-ray free-electron laser (XFEL) pulses
of a few femtoseconds duration, serial femtosecond crystallography (SFX) has already been
shown to overcome resolution limits imposed by radiation damage at conventional synchrotron
sources, allowing serial diffraction data collection from unprecedentedly small protein crystals
down to the nanometer regime.23,24 Tens of thousands of Bragg-diffraction snapshots from indi-
vidual, randomly “oriented” crystals are recorded at room temperature (RT) and then combined
into a dataset applying new data-processing tools25–27 to produce interpretable electron density
maps. Since each pulse destroys the individual crystal, samples need to be constantly supplied
by injection in vacuum into the pulsed XFEL beam using microjet techniques.28,29 The feasibil-
ity of this concept to elucidate protein structures at high resolution has already been demon-
strated on several examples.23,24,30–34 One of the important milestones in SFX development,
namely, the elucidation of the first new bioinformation by applying this approach, has been
obtained using protein crystals that spontaneously grew within living baculovirus-infected Sf9
insect cells during gene over-expression.30 In addition to the applicability of SFX techniques,
we recently showed that comparable structural information on fully glycosylated and natively
inhibited Trypanosoma brucei procathepsin B could be obtained from the same in vivo crystals
combining a micron-sized synchrotron beam with high-precision diffractometry and a helical
line scan approach.35 Although the resolution of the diffracted synchrotron radiation was
slightly reduced, which indicates the need for further methodological and technical improve-
ment. Particularly, optimization of the sample mounting and a more focused X-ray beam are
currently in discussion.35 Both studies clearly illustrated that in vivo crystals can indeed act as
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suitable targets for structural biology, if the enormous potential of the highly brilliant XFEL
and third-generation synchrotron radiation sources is exploited. This significantly supports and
extends initial studies reporting the successful structure solution from in vivo-produced polyhe-
dra at microfocus synchrotron beamlines.16,36,37
The number of in vivo crystallization observations reported as a consequence of heterologous
gene expression increased within the past years,18,20,38 but crystal formation within a living cell
still represents a spontaneous event that is detected by chance. A broader application of in vivo
grown protein crystals as valuable targets for structural biology requires a detailed and systematic
investigation of the intracellular processes involved in crystal formation. If identified, the modifica-
tion of suitable biological parameters that influence crystal growth could significantly increase the
chance of successful protein crystallization within living cells, comparable to multidimensional pa-
rameter screens performed in conventional crystallography. Such biological parameters could
include, for example, the localization of the protein in a specific cellular compartment as well as
the up or down regulation of distinct cellular pathways impacting on protein degradation or traf-
ficking. In this context, we analysed the spontaneous crystal formation of two proteins in Sf9 insect
cells, namely, firefly luciferase and a part of the avian reovirus (ARV) nonstructural protein lNS
(residues 448-605) fused to Green Fluorescent Protein (GFP) (referred to as GFP-lNS). Applying
live-cell imaging techniques, we obtained first real-time insights into the dynamic crystallization
process in a living cell, together with new results in terms of cellular localization, stability, and dif-
fraction capabilities of the in vivo grown protein crystals, which are discussed in this study.
II. EXPERIMENTAL METHODS
A. Recombinant baculovirus generation and gene expression
The construction of the recombinant baculoviruses Bac-luc, which expresses full length lu-
ciferase from Photinus pyralis (American firefly), and Bac-GFP-lNS, which expresses GFP-
lNS (448–605) from the avian reovirus S1133 strain, have previously been described.39,40 For
baculovirus–driven expression of mCherry labeled organelle marker proteins, Pex3-mCherry,41
Pex26-mCherry,41 and mCherry-KDEL42 were subcloned into pFastBac1 using EcoRI and XbaI
restriction enzymes. The construction of recombinant baculoviruses and subsequent generation
of high-titer virus stocks were performed according to the Bac-to-Bac manual (Invitrogen).
Recombinant high-titer virus stocks (P3) were used to infect 70%-confluent monolayer cultures
of Sf9 insect cells (an insect cell line derived from Spodoptera frugiperda (ATCC CRL-1711,
Invitrogen) with a multiplicity of infection of 0.1 p.f.u. per cell. Sf9 cells were grown in serum-
free EX-CELL 420 insect cell medium (Sigma) supplemented with 100 units/ml penicillin and
100 lg/ml streptomycin at 26 C.
B. Microscopy and live cell imaging
Transiently transfected or baculovirus infected Sf9 cells were plated on glass coverslips
and adherent cells were imaged using a laser confocal spinning disk microscope system based
on a Nikon Ti Eclipse microscope equipped with the confocal spinning unit CSU-X1 and an
Andor iXonþEM-CCD (electron multiplier-charge coupled device) camera. The microscope
was fitted with 40, 1.30 NA and 100, 1.49 NA objectives. Image acquisition was controlled
with Andor Bioimaging software (Andor IQ2.1). Protein crystal growth and dynamics in living
Sf9 cells were recorded by time-lapse microscopy using differential interference contrast (DIC)
optics over a period of several days or, in the case of GFP-lNS, using a combination of DIC
microscopy and GFP fluorescence that was elicited with a 514 nm laser. For 3D images of liv-
ing cells, z-stacks were taken with images every 300 nm. Three dimensional reconstruction and
animation were done in Andor IQ2.1.
Cells infected with recombinant Bac-luc and Bac-GFP-lNS have been subjected to propi-
dium iodide (PI) staining43 to detect dead cells in the culture and to BODIPY
VR
558/568 C12
(Life Technologies) treatment for staining of internal cellular membranes. Cells were plated on
25 mm glass coverslips at 50% confluence and infected with 5 ll high titer baculoviral P3
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stocks per ml of culture medium. At 4 days p.i., cells were mounted on the live cell microscope
described above and stained with 500 ng/ml propidium iodide (Invitrogen) or 10 lg/ml
BODIPY
VR
558/568 C12 in culture medium at 26
C for 30 min and 10 min, respectively. The
marker molecules were excited with 561 nm laser light and imaged with appropriate filter set-
tings.44 Staining of lysosomes and mitochondria was performed with LysoTracker Deep Red
and MitoTracker Deep Red, respectively (both from Life Technologies). Cells were plated and
infected as described above. At 4 days p.i., cells were mounted on the live cell microscope and
stained with 40 nM LysoTracker or 7 nM MitoTracker in culture medium for 15 min at 26 C.
Fluorescence was elicited with 640 nm laser light and imaged with appropriate filter settings.
For co-localization of firefly luciferase crystals with fluorescent organelle marker protein,
chimeras cells were plated at 50% confluence and co-infected with identical amounts of
recombinant baculovirus stocks expressing luciferase and the marker. Potential co-localization
of luciferase with mCherry-KDEL (a marker for the endoplasmic reticulum (ER)) as well as
Pex3-mCherry and Pex26-mCherry (peroxisome organelle markers) were analyzed 3 days and 4
days p.i., respectively. The marker proteins were excited with 561 nm laser light and imaged
with appropriate filter sets.
In vivo activity of luciferase was examined by addition of the plasma membrane-permeable
D-luciferin ethyl ester (Marker Gene Technologies) to cells infected with recombinant baculovirus
expressing luciferase.45 Cells were plated and infected as described above. 4 days p.i. cells were
mounted on the microscope stage and imaged with DIC optics and a YFP (Yellow Fluorescent
Protein) filter set for luciferin bioluminescence. During ongoing image acquisition, the culture
medium was supplemented with D-luciferin ethyl ester at a final concentration of 100 lM.
C. Virus-free gene expression
The gene coding for firefly luciferase (GenBank: KC152483.1 firefly luciferase 1157–2809)
was amplified from the pFastBac1 vector template (Invitrogen) by polymerase chain reaction (PCR)
using primers 50-GATCGGATCCATGGAAAACATGGAAAACGATGAAAATATTGTAGTT-30
(sense) and 50-GATCCTCGAGCATCTTAGCAACTGGTTTCTTAAGGATTTCTCTAAT-30 (anti-
sense). After restriction with NotI and BamHI, the PCR product was cloned into a modified
pIEX4 expression plasmid (Novagen) lacking the internal start codon. Following transformation
into competent DH5a Escherichia coli cells, the amplified plasmid was isolated (QIAprep Spin
Miniprep Kit, Qiagen) and sequenced. Transient transfection of a monolayer culture with
0.5 106 Sf9 insect cells per ml was performed by lipofection with ESCORT transfection reagent
(Sigma). Cells were grown and maintained in serum-free medium at 27 C. Transfection of Sf9
cells with expression constructs encoding chimeric proteins, corresponding DNA cloning, and
plasmid purification have essentially been performed as previously described.46
D. GFP-lNS crystal isolation and stability tests
Baculovirus-infected Sf9 cells were harvested at 96 h p.i. and lysed by incubation in hypo-
tonic buffer (10 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid (HEPES) pH 7.9,
10 mM KCl, and 5 mM MgCl2) for 30 min at RT. Crystals were separated from the cell debris
by centrifugation for 10 min at 200 g and collected from the supernatant. Complete protease
inhibitor (Roche) was added at recommended concentration to prevent crystal degradation. For
dot blot stability analysis, 10 ll of a crystal suspension containing approximately 106 crystals
per ml was pelleted for 5 min at 14 000 g and resuspended in 20 ll of an appropriate test
buffer. After 1 h, 2 h, and 21 h, respectively, samples were centrifuged for 5 min at 14 000 g
and 5 ll aliquots were taken from the crystal-free supernatant, followed by spotting of 1 ll of
each sample on a nitrocellulose membrane. Solubilized protein from the crystals was quantified
using a monoclonal anti-GFP antibody (1:1000, Roche), followed by detection with a goat anti-
mouse IgG antibody coupled to horse radish peroxidase (HRP) (1:5000, Santa Cruz). In addi-
tion, stability of GFP-lNS crystals was analyzed by visual inspection using a Leica DMIRE2
fluorescence microscope with the crystals resuspended and incubated in appropriate test buffers
for 30 min to 21 h.
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E. Scanning electron microscopy (SEM)
After cell lysis, 50 ll GFP-lNS crystal suspension was centrifuged for 5 min at 14 000 g
and the hypotonic buffer was exchanged by ultra-pure water to remove excess salt and buffer
components. A 2 ll crystal aliquot was spotted onto a polished silicon sample carrier and air
dried for 15 min. Scanning electron microscopy was performed using an FEI Helios Nanolap
microscope operated at a chamber pressure of 106 bar with an electron acceleration voltage of
5 kV and a current of 0.89 pA.
F. Synchrotron diffraction test of GFP-lNS crystals
A suspension of isolated GFP-lNS crystals in hypotonic buffer with or without a supple-
ment of 30% polyethylene glycol (PEG)400 (v/v) or 30% glycerol (v/v) was pipetted into a
glass capillary with a diameter of 0.5 mm. After centrifugation for 15 min at 1000 g, a dense
crystal pellet was clearly visible at the bottom of the capillary. The capillary was sealed with
crystal wax and powder diffraction was performed with a microfocus synchrotron beam of 4 
5 lm FWHM at the EMBL-operated P14 beamline at PETRAIII storage ring (DESY, Hamburg,
Germany) with exposure times between 0.1 and 1 s, a photon flux of 1012 ph/s, and a photon
energy of 10.00 keV.
III. RESULTS AND DISCUSSION
lNS is a protein from pathogenic ARV that causes important economic losses in poultry
industry.47 It forms ordered cytosolic inclusions inside infected cells, which are suggested to
constitute together with viral RNA and structural proteins the basic scaffold for so-called viral
factories that drive virus replication.39,40 So far, the structure of lNS is unknown, most likely
due to the inherent difficulty in crystallizing proteins with an intrinsic tendency to aggregate,
which usually prevents obtaining soluble protein in concentrations suitable for crystallization.
Since the efficient auto-assembly of lNS, particularly of the C-terminal part comprising resi-
dues 448–605, is not affected by an N-terminal GFP fusion,39 the linked fluorescence enables
direct insights into the spontaneous assembly process, which might result in a crystalline state
of lNS suitable for diffraction data collection.
Luciferase catalyzes the reaction of luciferin, Mg-ATP (adeonsine triphosphate), and mo-
lecular oxygen, yielding electronically excited oxyluciferin that emits visible light during relax-
ation to its ground state.48 The color of this bioluminescence, which is involved in the commu-
nication of fireflies, changes by subtle structural differences in luciferase during the emission
reaction which has already been elucidated applying x-ray crystallography.49 In cells of the fire-
fly’s lantern organ, luciferase is localized within peroxisomes due to its native C-terminal
“SKL” (i.e., the tripeptide serine - lysine - leucine) import signal.50,51 These highly dynamic or-
ganelles contain more than 50 different enzymes, some of them typically assemble into regular
crystals that can be both co-crystals of a mixture of enzymes or pure crystals of one enzyme
depending on the cell type involved.8,52 Thus, peroxisomes were already known to act as a suit-
able cellular compartment for native protein crystallization in vivo. Since light excitation is not
required for luciferase bioluminescence, this enzyme is commonly used in biological research
as a virtually background-free luminescence reporter.53–55 In this context, we serendipitously
observed spontaneous in vivo crystallization of firefly luciferase in insect cells when we used
this enzyme as a model to test a new method of active enzyme purification by recruitment into
lNS microspheres.40
A. In vivo crystallization of firefly luciferase in Sf9 insect cells
1. Crystal growth is dynamic and not limited by cell size
Approximately 72 h after infection, the formation of needle-shaped microstructures started
to be visible by DIC or phase contrast light microscopy in Sf9 insect cells infected with
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recombinant baculovirus that contained the gene encoding full-length firefly luciferase. The
crystal morphology was similar to that previously reported after luciferase crystallization using
conventional in vitro techniques.56,57 Crystal growth continued up to day 5 p.i., regularly
exceeding the normal dimensions of the Sf9 cells (which are 15–20 lm in diameter) by many
times (Figure 1(a)). The majority of cells gradually lysed thereafter, largely attributable to the
ongoing viral replication process rather than to plasma membrane disruption by the growth of
the in vivo crystals. This assumption is based on visual inspection of the cell culture as well as
live-cell microscopy. Degradation of the plasma membrane as a result of the tension generated
by the growing crystal would lead to a sudden rupture of the membrane at one of the crystal
tips, which was not observed. In contrast, we detected a slow disintegration of the plasma mem-
brane or cell blebbing followed by plasma membrane rupture around the cell body, which is
characteristic for cell lysis due to viral replication. In contrast to the previous observations with
Sf9 cells that produced cathepsin B crystals,38 no free luciferase crystals floating in the medium
or attached to cell remnants were detected, indicating significantly reduced crystal stability out-
side the intact cell compared to cathepsin B. Remarkably, individual luciferase crystals showed
a dynamic degradation and re-assembly within the same living cell over the entire growth pe-
riod observed by time-lapse DIC microscopy (Figure 1(b)). This phenomenon was routinely
detected for a small, but significant number of luciferase crystals in the Sf9 cell cultures. The
molecular and cellular basis for this unexpected dynamic behaviour of in vivo crystals, which
has, to our knowledge, not been reported for crystals grown in living cells so far, will be inves-
tigated in further studies. However, a direct response to changes in the environment surrounding
the crystals, e.g., in the levels of recombinant gene expression or in the nutrition state of the
cell, appear to be reasonable parameters to test further.
During the progress of infection, the number of crystals continuously increased until more
than 50% of the cells contained up to five crystals per cell, at day 5 p.i. When several crystals
were present in the same cell, they were either individually separated or stuck together to form
crystalline superstructures. Luciferase crystals were characterized by extraordinary dimensions
FIG. 1. Time-resolved in vivo crystal growth of firefly luciferase in Sf9 insect cells recorded by life-cell imaging with DIC
optics. Cells were plated to 40% confluence on glass coverslips and infected with recombinant P3 luciferase virus stocks. 3
days p.i. cells were put on the live cell microscope and imaged for 67 h. (a) Luciferase crystals grew slowly over the entire pe-
riod of 67 h from 70 to 100 lm in length. (b) Luciferase in vivo crystallization can be dynamic. In the example show, the crys-
tal shrinks within 33 h from 61lm to about the cell diameter (15 lm) and starts growing again to a final length of 37lm.
(Multimedia view) [URL: http://dx.doi.org/10.1063/1.4921591.1] [URL: http://dx.doi.org/10.1063/1.4921591.2]
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up to 200 lm in length, depending on the respective growth state. However, the width of the
crystals only varied between 1 and 3 lm (Figure 2(a)). Presenting the largest in vivo crystals
reported so far, our study clearly demonstrates that the size of such crystals can indeed exceed
the cells outer dimensions by several-fold, in strong contrast to prevalent suggestions in the cur-
rent literature.8,21 All previously reported in vivo crystals grown within bacteria,14 insect
cells,16,17,58 or mammalian cells18,20 were always restricted by the normal cell volume, without
inducing alterations to cell morphology. Only our recently reported cathepsin B study provided
a first indication that protein crystal length is not generally limited by the cell diameter.38
2. Membrane surrounded crystals originate from peroxisomes
Despite the substantial length of the luciferase in vivo crystals, cell viability is not affected,
as revealed by the plasma membrane-impermeable DNA intercalating dye PI (Figure 2(b)). PI
stains the DNA in nuclei of cells with compromised plasma membrane integrity brightly red,
immediately after membrane disruption.44 Thus, the absence of PI positive nuclear signals for
cells containing large luciferase crystals provided evidence for an exceptional expansion of the
plasma membrane of the living cell to cover the entire crystal, as also indicated by DIC micros-
copy (Figure 2(a)). Applying the lipid droplet stain BODIPY
VR
558/568 C12 with a short incuba-
tion time,59 we detected additional internal membranes within the cell body that covered the
crystals next to the plasma membrane, suggesting a growth from a specific cellular compart-
ment (Figure 2(c)). As expected due to the presence of a corresponding native C-terminal per-
oxisome import signal,50 co-infection with recombinant baculoviruses expressing genes for the
FIG. 2. Morphology and intracellular localization of in vivo firefly luciferase crystals. (a) Luciferase crystals can be extraor-
dinarily long. The dimensions of the luciferase crystal inside a living cell pictured are 206 lm  3 lm. Note that the diame-
ter of the Sf9 cell body is only 21 lm. (b) Dead cells in the culture were identified by strong red nuclear fluorescence by
addition of the membrane impermeable DNA-binding dye propidium iodide (at 500 ng/ml) to the culture medium at 4 days
p.i. with recombinant baculovirus. Cells harboring crystals show no nuclear fluorescence establishing that their plasma
membranes were intact. (c) Bodipy 558/568 staining a membrane surrounding a luciferase crystal. A 3D reconstruction of a
z-stack of confocal fluorescence images is shown. (d) Firefly luciferase crystals are surrounded by peroxisomal membranes.
Cells were co-infected with recombinant firefly luciferase and baculovirus expressing the peroxisomal membrane marker
protein Pex26 fused to mCherry. Confocal images recording the DIC and the mCherry fluorescence channels were taken 4
days p.i. Note that the internal membrane surrounding the crystal is clearly labeled with the peroxisomal marker protein.
(Multimedia view) [URL: http://dx.doi.org/10.1063/1.4921591.3] [URL: http://dx.doi.org/10.1063/1.4921591.4]
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peroxisomal marker proteins Pex3 and Pex2641 confirmed an origin of luciferase in vivo crystals
from Sf9 cell peroxisomes. The fluorescence detected clearly surrounded the crystals (Figures
2(d) and S1(b)).60 In contrast, no co-localization was detected after co-infection with an ER
specific marker, mCherry-KDEL42 (Figure S1(a)).60 While cathepsin B that contains a native
N-terminal signal sequence for rough ER import and the respective in vivo crystals were sur-
rounded by membranes decorated with ribosomes, it was suggested to crystallize within the
rough ER of Sf9 cells;38 our data represent the first proof that crystallization of a recombinant
protein can also occur in peroxisomes of living insect cells. Thus, depending on the protein and
on the trafficking signals harboured in its primary sequence, different organelles may promote
crystal formation. In mammalian Chinese hamster ovary (CHO) cells, successful human IgG
crystallization was reported to occur also within the ER lumen after heterologous expression
and translocation of the recombinant protein into the ER.18,19
Since baculovirus replication is localized within the nucleus of the infected insect cells,61 a
direct impact of viral proteins or of the replication process itself on the spontaneous crystalliza-
tion of luciferase within peroxisomes appeared unlikely. However, to directly test this, we
investigated virus-free transfections of Sf9 cells with a pIEX4 vector that contained the full-
length luciferase cDNA. Strikingly, crystals comparable in size and morphology to those
obtained in baculovirus-infected Sf9 cells grew within 2 days, i.e., even in the absence of virus
(Figure S2),60 confirming that baculovirus acts only as a gene shuttle to import the gene of in-
terest into the insect cells. However, most crystal-positive cells contained only single crystals
and also the number of cells containing crystals was reduced after direct transfection, likely at-
tributable to decreased DNA transfection efficiency compared to the active viral DNA infec-
tion/replication process.
3. Enzyme activity or cell lysis lead to crystal degradation
Addition of a plasma membrane-permeable luciferin ethyl ester into the surrounding me-
dium resulted in detectable bioluminescence for several minutes in living Sf9 cells (Figure
S3).60 In addition to the regular cell body, the cell protrusions induced by luciferase crystals
could also be clearly traced. Mg-ATP, which is required for activation of luciferin by adenyla-
tion in the first step of the reaction,48 was here provided by the cellular environment. Yet, the
luciferase crystals completely dissolved in the intact cells within 70 s after first observable light
emission, as revealed by confocal and DIC microscopy (Figure S3).60 Degradation can be
attributed to the significant conformational movements associated with the catalytic cycle which
apparently destroyed the stabilizing crystal contacts.49 The fast degradation, however, confirmed
the structural and functional integrity of the luciferase protein within the in vivo crystal lattice.
Unfortunately, this effect prevents the investigation of the structural dynamics of in vivo crys-
tallized luciferase during enzymatic catalysis applying time-resolved SFX techniques. Online
investigation of biomolecules in action represents one of the current challenges in XFEL
science.62,63
Luciferase in vivo crystals did not exhibit significant stability after lysis of the cell mem-
brane. When the plasma membrane is disrupted by the viral replication, crystals dissolved
within hours in the surrounding culture medium (Figure 3(a)). Lysis of the cellular membranes
by addition of culture medium supplemented with 0.1% (v/v) Triton X-100 lead to much faster
dissolution of the crystals (Figure 3(b)). Exchange of cell medium against crystal extraction
buffer (50 mM HEPES pH 7, 50 mM KCl, 2.5 mM MgCl2, 2.5 mM CaCl2, 2% (v/v) sucrose,
and 0,1% (v/v) Triton X-100) increased the stability of the luciferase crystals up to 3 h (Figure
3(c)). This seemingly passive dissolution is in contrast to the active destruction of the crystals
by activation of luciferase enzyme activity under addition of luciferin ethyl ester, where the
crystals degrade within 70 s (Figure 3(d)). However, further improvement of the so far limited
crystal integrity will be required to isolate sufficient amounts of intact luciferase crystals for
x-ray diffraction tests and data collection at synchrotron or XFEL sources. In contrast to lucifer-
ase, cathepsin B and inosine-50-monophosphate dehydrogenase (IMPDH) formed crystals within
living Sf9 cells that were characterized by an extraordinary mechanical and chemical stability,
041712-8 Sch€onherr et al. Struct. Dyn. 2, 041712 (2015)
FIG. 3. Stability of firefly luciferase in vivo crystals. Cells were imaged 4 days p.i. with recombinant luciferase baculovirus
on a live cell imaging system. (a) The cell is lysed during image acquisition by the baculovirus. Immediately after cell mem-
brane rupture, the luciferase crystal starts to dissolve. It may take several hours for the crystal to dissolve, likely depending on
how much of the, presumably protective, membranes are still left around the crystal. (b) During image acquisition, the me-
dium was exchanged by culture medium supplemented with 0.1% Triton-X 100. In this case, cellular membranes were imme-
diately disrupted and crystals dissolved within 30 min. (c) During image acquisition, the medium was exchanged for a crystal
extraction buffer supplemented with 0.1% Triton-X 100. Cellular membranes were quickly disrupted like in (b), but the crys-
tals dissolved much slower. Crystal length was reduced on average only by 30% during 1 h of imaging. (d) During ongoing
image acquisition, medium was supplemented with 100 lM membrane-permeable D-Luciferin ethyl ester. This results in a
very fast breakdown of the luciferase crystals within 70 s in the intact cells, probably caused by activation of the enzyme.
(Multimedia view) [URL: http://dx.doi.org/10.1063/1.4921591.5] [URL: http://dx.doi.org/10.1063/1.4921591.6] [URL: http://
dx.doi.org/10.1063/1.4921591.7] [URL: http://dx.doi.org/10.1063/1.4921591.8]
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which allowed the structure elucidation of cathepsin B directly from isolated in vivo
crystals.30,38
B. In vivo crystallization of GFP-lNS fusion protein in Sf9 insect cells
1. Nucleation and crystal growth occur in the cytosol
Production and assembly of GFP-lNS within Sf9 insect cells can be easily monitored after
infection with the recombinant baculovirus due to the intrinsic GFP fluorescence In this case,
GFP-lNS did not contain any native or artificially added transport signal for a specific cellular
compartment. Thus, translation of the fusion protein occurred probably within the cytosol, as
observed by increasing diffuse, ubiquitous fluorescence within the entire Sf9 cell starting 24 h
after baculovirus infection. Accumulation of GFP molecules into several tiny dots at 77 h p.i.
indicated formation of initial crystal nuclei (Figure 4). However, most crystal nuclei exhibited a
transient character. Only few crystal nuclei grew into macroscopic visible structures that
reached final dimensions of 10 lm in length and 3 lm in width at day 4 p.i., but without
exceeding the regular cell diameter. Consequently, the morphology of the Sf9 cells was not
FIG. 4. Time-resolved in vivo crystal growth of GFP-lNS in Sf9 insect cells recorded by life-cell imaging with DIC optics
and GFP fluorescence. Crystal growth was imaged 3 days p.i. over night. (a) GFP-lNS is expressed in the cytoplasm and
displays a ubiquitous diffuse fluorescence together with a variable number of dots with higher fluorophore concentration.
(b) Some of those dots apparently act as crystallization points and start to grow by accumulating more protein. (c) Crystals
are fully grown. Background fluorescence in the cytoplasm is still visible as well as several crystallization nuclei that did
not grow out into a full crystal. (Multimedia view) [URL: http://dx.doi.org/10.1063/1.4921591.9]
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affected by GFP-lNS in vivo crystallization, despite being much more efficient than the crystal-
lization of luciferase. Almost all cells in the entire culture were found to be positive for GFP-
lNS crystals. Remarkably, neither dynamic crystal growth nor crystal degradation, as observed
for luciferase, was detected for these macroscopic GFP-lNS structures.
The mature GFP-lNS assemblies exhibited an elongated, almost needle-shaped morphology
with a hexagonal cross section (Figure 5(b)), but, in contrast to luciferase, bundled needles
forming star-shaped superstructures were observed (Figures 5(a) and 5(c)). Crystals were visible
in living cells showing no PI staining as well as in cells positively stained with PI (Figure
5(d)). This result shows that general cell viability was not affected by GFP-lNS crystallization
and that these crystals exhibit a much higher intrinsic stability compared to luciferase crystals.
A strong intrinsic tendency for auto-assembly represents the physiological function of the
viral lNS domains in the process of viral replication factory formation, natively occurring in
the cytosol of reovirus-infected cells.39,40 As reported above for luciferase, in vivo crystalliza-
tion of GFP-lNS did not depend on baculovirus infection. Spontaneous assembly formation
was previously detected in primary cultures of chicken embryo fibroblasts (CEF) directly trans-
fected with a plasmid expressing GFP-lNS.39 The mature GFP-lNS assemblies grown in CEF
were comparable in size and morphology to the structures observed after baculovirus infection
of insect cells.
Another remarkable phenomenon that has not been described before is that different pro-
teins can crystallize in the same cell (Figure S4).60 After co-infection with Bac-luc and Bac-
GFP-lNS viral stocks, following the previously described protocol for co-infection experiments
with recombinant viruses expressing marker proteins, both in vivo crystal species were simulta-
neously detected in some cells. These crystals showed no obvious alterations in their
FIG. 5. Morphology of GFP-lNS in vivo crystals. Cells were infected with recombinant GFP-lNS baculovirus and incu-
bated for 3 days. Subsequently, cells were imaged on a confocal fluorescence microscope system. (a) Mostly, rod-like crys-
tals can be seen, routinely with several crystals per cell. Crystals inside cells can be separated (arrow 1) or lying parallel to
each other (arrow 2), or they arranged in a star-like fashion (arrow 3). The length of the crystals does not exceed the diame-
ter of the cell body. The diameter of the crystals varies between <1 and 5 lm. (b) The fluorescent GFP-lNS crystals show
a hexagonal profile in confocal cross sections (arrows). (c) A 3D reconstruction of a z-stack of confocal fluorescence
images is shown. Several packs of crystals in a star like arrangement can be seen. (d) Dead cells were identified by adding
the membrane impermeable dye propidium iodide (500 ng/ml) at 4 days p.i. Note that crystals are visible in both cells with
or without red nuclear fluorescence, demonstrating that GFP-lNS crystals are stable after cell lysis caused by baculovirus
reproduction. (Multimedia view) [URL: http://dx.doi.org/10.1063/1.4921591.10]
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morphology compared to corresponding crystals individually grown in different cells, indicating
no direct impact of GFP-lNS and luciferase on each other during crystal formation. This can
be explained by crystallization events occurring in different cellular compartments. As shown
in this study, luciferase crystals grow in peroxisomes, while GFP-lNS is suggested to crystal-
lize within the cytosol. Thus, expression of either of the proteins did not change the cellular
environment of the other.
2. Isolated crystals show intrinsic stability
As previously reported for cathepsin B,30,38 isolation of in vivo grown GFP-lNS crystals was
performed by membrane disruption and differential centrifugation without apparent crystal dam-
age. Since cell lysis is associated with extreme changes in the environmental conditions of the
in vivo crystals, the identification of buffers conferring optimal stability represents an important
requirement to maintain maximum crystalline order after extraction. We applied dot blot techni-
ques to enable large-scale screening of various environmental conditions, including pH value and
different concentrations of cryo-protectants. Extracted GFP-lNS crystals were incubated for up to
21 h in the test buffer, followed by centrifugation and highly sensitive immunochemical detection
of solubilized protein in the supernatants (Figure S5(a)).60 The isolated crystals were stable in
high- or low-salt solutions and acidic buffers but became soluble in alkaline buffers above pH 10.
Moreover, glycerol and PEG 400, both up to 40%, were identified as suitable cryo-protectants for
potential single-crystal diffraction tests applying synchrotron radiation. Supplement of PEG400
increased the stability of GFP-lNS crystals, in general, even preventing the rapid dissolution at
pH 10. Our screening experiments additionally revealed that Mg2þ ions were essential for the sta-
bility of the macroscopic structure of GFP-lNS crystals outside of their natural cellular environ-
ment. Disruption of the cell membrane in buffers without Mg2þ ions resulted in immediate diver-
sification of the crystals (Figure S5(b)).60 Most noteworthy, GFP-lNS in vivo crystals withstood
even dry conditions in vacuum during SEM analysis without any disruption into small fragments,
as usually expected for protein crystals, revealing the high intrinsic stability (Figure 6(a)).
Although SEM analysis showed roundish edges of the individual assemblies, the perfectly flat
surfaces strongly supported a crystalline character of the GFP-lNS assemblies.
3. Powder diffraction reveals crystalline state
The formation of GFP-lNS assemblies within living cells has previously been reported, but
the detected microstructures were not considered to consist of an ordered crystalline lattice so
FIG. 6. Surface morphology and diffraction quality of GFP-lNS crystals. (a) Extracted GFP-lNS crystals were spotted
onto a sample carrier and applied to SEM. The depicted crystal has a smooth and highly regular surface and a size of 15 lm
 2 lm. Moreover, it retains its rod-shaped morphology even under vacuum conditions, indicating its remarkable intrinsic
stability. (b) GFP-lNS crystals were pelleted in a glass capillary and analyzed by synchrotron powder diffraction experi-
ments. The pattern reveals weak diffraction of approximately 30 Å, confirming a crystalline state.
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far.39,40 However, the exceptional stability and the regular crystalline appearance of the GFP-
lNS in vivo crystals (Figures 5(b) and 6(a)) determined in this study qualified them for syn-
chrotron diffraction tests. Crystals grown in suspension culture of baculovirus-infected Sf9 cells
were extracted 4 days p.i. and centrifuged to remove excess of cell remnants. Powder diffrac-
tion tests have been performed at the EMBL-operated microfocus beamline P14 of the PETRA
III synchrotron source (DESY, Hamburg, Germany). The detection of typical Debeye-Scherrer
rings generally verified the crystallinity of the GFP-lNS assemblies (Figure 6(b)). Amorphous
material would have produced a broad and continuous background signal instead of sharp dif-
fraction rings, which are the result of constructive interference of the incident x-rays with the
electrons in the well-ordered lattice satisfying Bragg’s law. However, the very low maximum
resolution of around 30 Å detected for the diffracted x-rays that have not been improved so far
by testing other buffer conditions, e.g., including 30% PEG 400 or 30% glycerol as cryo-
protectants for potential single-crystal diffraction experiments, prevented the use of GFP-lNS
in vivo crystals as suitable targets for x-ray crystallography. Assuming that lNS forms the regu-
lar crystal lattice driven by its high intrinsic assembly tendency,39 the fusion of GFP may have
disturbed crystal order by increasing the overall flexibility of the protein, thus interfering with a
well-ordered crystal lattice. On the other hand, a direct impact of the extraction process and the
non-native buffer conditions which might damage the in vivo crystals can also not be excluded.
Consequently, in cellulo diffraction data collection represents a suitable trail to compare the dif-
fraction data quality before and after crystal isolation. Interestingly, substitution of the GFP
moiety by the C-terminal tail of lNS significantly changed the morphology of the lNS crystals
into a globular shape.39 The crystalline character and the diffraction properties of globular pure
lNS assemblies are currently under investigation.
IV. CONCLUSIONS
Convincing examples, particularly the pioneering structure elucidation of insect virus poly-
hedra16,21,36 and of the native B. thuringiensis toxin Cry3A,34 but also the high-resolution struc-
ture determination of cathepsin B,30,35 as well as the SFX diffraction tests performed with pro-
tein crystals formed in mammalian and cockroach cells,20 already demonstrated the feasibility
to implement in vivo crystallography at XFEL and third-generation synchrotron sources as a
new strategy for structural biology. However, the general applicability to crystallize any kind of
protein within a living cell is so far questionable, even if the number of spontaneous crystalliza-
tion observations significantly increased, involving various cell types.
In the present study, we report the crystal formation of two new examples, firefly lucifer-
ase and avian reovirus lNS, upon high-level heterologous expression in living Sf9 insect
cells. Together with polyhedrin from Bombyx mori cytoplasmic polyhedrosis virus,64 cathep-
sin B and IMPDH from T. brucei38 as well as calcineurin,17 six successful in vivo crystalliza-
tion events are now described. All of those examples occur during gene over-expression in
these cells, indicating a more general phenomenon. Providing first evidence that recombinant
proteins can crystallize in peroxisomes of insect cells, we identified the cellular compartment
of crystal origin as an initial parameter that could influence successful crystal growth. Most
strikingly, our live-cell imaging studies not only provided real-time insights into the spontane-
ous crystallization process in living cells but also clearly revealed that the normal outer cell
dimensions do not limit the crystal size and that the in vivo crystallization process can be
highly dynamic, disproving the previous suggestions. These important results represent the
starting point for a detailed and systematic investigation of the cellular crystallization mecha-
nisms in living insect cells, which is currently ongoing in our group. The identification of
additional cellular parameters next to the compartment will enable a systematic screening of
target proteins to optimize the success rate of this novel approach. The dynamics detected for
luciferase in vivo crystals suggest an active involvement of cellular processes, e.g., protein
and membrane transport mechanisms, in intracellular crystallization, which will be investi-
gated and identified in future studies.
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The confirmation that in vivo crystals grown within insect cells are not necessarily charac-
terized by an extraordinary intrinsic stability outside of their natural environment, as we have
previously suggested based on our experience with cathepsin B and IMPDH38 and shown here
for GFP-lNS, represents another important result of our study. This shifts diffraction data col-
lection from in vivo crystals directly within the living cells, denoted as the “in cellulo”
approach,21 into focus, which would avoid crystal damage arising from the non-physiological
environmental conditions after crystal extraction. In cellulo data collection has already been
tested by injecting tiny bacterial cells into XFEL pulses34 as well as by mounting frozen intact
insect cells directly in a synchrotron beam,21 both providing first evidence that background scat-
tering from other cell components did not obscure the Bragg diffraction from in vivo grown
protein crystals. Due to their enormous size, the luciferase crystals reported here represent
highly interesting candidates for an in cellulo data collection experiment using synchrotron radi-
ation in the future. However, particularly, the microjet-based sample injection techniques of the
SFX approach need optimization, since the comparatively large insect cells require large gas
focused liquid jets to avoid clogging of the nozzle, which in turn would result in high back-
ground scattering.20 On the other hand, the systematic investigation of crystal stabilization trials
directly in the living cell or the improvement of the crystal extraction procedure for instable
crystals will enhance the chance to collect suitable diffraction data from in vivo crystals apply-
ing well-established SFX or serial synchrotron crystallography techniques.30,35,65 In this context,
the dot blot approach proposed in this study appears to be highly suitable for large-scale screen-
ing of appropriate buffer conditions in terms of securing maximum stability of isolated in vivo
crystals.
Comparing the crystal morphology of luciferase and GFP-lNS with that of previously
reported T. brucei cathepsin B30 and IMPDH38 indicates a preference for needle-like crystals
in vivo, which renders conventional synchrotron diffraction data collection difficult due to the
small size of the short crystal axis. Moreover, flow alignment of the elongated cathepsin B
in vivo crystals during microjet-based sample injection increased the required amount of diffrac-
tion data to cover all crystal orientations in SFX experiments.30 On the other hand, a preferred
orientation due to the needle-like shape could help to obtain angular information in SFX experi-
ments, particularly if fixed-target sample delivery that was recently reported for SFX techni-
ques66 will be improved to allow sample mounting for in a specific, well-defined orientation in
the future. Full sampling of reciprocal space will be allowed by the use of a goniometer stage
that rotates the normal vector of the fixed target support relative to the incident XFEL pulses,
while proof-of-principle experiments indicated dramatically reduced sample consumption com-
pared to flowing jet methods.66
Successful protein crystallization within living cells would abolish the need for time-
consuming optimization of recombinant protein production and conventional crystallization
strategies. Thus, this approach offers exciting new possibilities for proteins that do not form
crystals suitable for x-ray diffraction in vitro, if the associated cellular mechanisms will be
understood in more detail in the future.
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